Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Niemann, Carsten Utoft; Levin, Mark-David; Dubois, Julie; Kersting, Sabina; Enggaard, Lisbeth; Veldhuis, Gerrit J; Mous, Rogier; Mellink, Clemens H. M.; Dobber, Johan A; Poulsen, Christian B.; Frederiksen, Henrik; Janssens, Ann; Schjødt, Ida; Dompeling, Ellen C; Ranti, Juha; Mattsson, Mattias; Bellido, Mar; Tran, Hoa T T; Nasserinejad, Kazem; Kater, Arnon P.
(2021) Blood, volume 137, issue 8, pp. 1117 - 1120
(Comment)
Download/Full Text
The full text of this publication is not available.
Keywords: Biochemistry, Immunology, Hematology, Cell Biology
ISSN: 0006-4971
Publisher: American Society of Hematology
Note: Funding Information: The work was supported by AbbVie and Janssen who also provided study drugs and had the option to comment on the manuscript. Funding Information: The authors thank all participating patients, local data managers for study coordination and patient data collection, local investigators, and, in particular, the study team at the HOVON Data Center at the Erasmus MC Cancer Institute and the 2 central laboratories at Amsterdam UMC and Rigshospitalet. The work was supported by AbbVie and Janssen who also provided study drugs and had the option to comment on the manuscript. The investigators are independent data owners with unrestricted publication rights.
(Peer reviewed)